Laetitia SzallerGeneral Counsel and Head of Compliance at Egetis TherapeuticsSpeaker
Profile
Laetitia brings over two decades of diverse experience spanning various industries, with a commendable 17 years dedicated to the pharmaceuticals and medical device sector. Her expertise extends to steering and overseeing intricate multi-jurisdictional operations, including the orchestration of global multimillion-dollar M&A transactions, licensing agreements, and collaborative partnerships.
In her current role at Egetis Therapeutics, where she assumed responsibilities in December 2023, Laetitia manages the global legal and compliance functions, as well as enterprise risk management. Prior to this, she played a pivotal role in the Legal operations and Corporate Development at AM-Pharma. Her professional journey also includes significant contributions at UCB as the global Associate General Counsel for BD, M&A, and Antitrust, as well as the Legal Director for Emerging Markets EMEA, Central European Region, and Benelux at Zoetis (formerly Pfizer's animal health division). Laetitia has also spearheaded the EMEA legal department for the Abbott Vascular division at Abbott. Beyond the healthcare realm, she held notable global positions at the Carlson Rezidor Hotel Group and in the automotive division (Wabco) at American Standard.
Laetitia holds qualifications as a lawyer in both the UK and Belgium, showcasing her extensive international experience. Renowned for her insights, she is a regular speaker at various legal conferences, contributing her wealth of knowledge and expertise to the legal community.
Agenda Sessions
Article 102: Update on the Draft Guidelines & Recent Case Law
, 13:10View Session